P Oudshoorn - JoVE Visualize

Showing results (11-20 of 18) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 18 results.

Immunotechnology : an International Journal of Immunological Engineering|May 7, 1999

Vernier zone residue 4 of mouse subgroup II kappa light chains is a critical determinant for antigen recognitionH de Haard, B Kazemier, A van der Bent, et al.

Journal of Virological Methods|September 23, 1997

Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QTS M Bruisten, P Oudshoorn, P van Swieten, et al.

Protein Engineering|February 4, 1999

Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct foldingH J de Haard, B Kazemier, A van der Bent, et al.

Journal of Medical Virology|January 1, 1997

Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjectsA Cerino, M Bissolati, A Cividini, et al.

Clinical Nutrition ESPEN|May 23, 2017

Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetesK A Berk, T P Oudshoorn, A J M Verhoeven, et al.

The Journal of General Virology|January 8, 1999

Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoireJ J de Haard, B Kazemier, P Oudshoorn, et al.

Journal of Clinical Microbiology|May 15, 1999

Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as targetM P de Baar, A M van der Schoot, J Goudsmit, et al.

AIDS Research and Human Retroviruses|October 29, 2000

Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptationsD W Notermans, F de Wolf, P Oudshoorn, et al.

Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 18 results.

Immunotechnology : an International Journal of Immunological Engineering|May 7, 1999

Vernier zone residue 4 of mouse subgroup II kappa light chains is a critical determinant for antigen recognitionH de Haard, B Kazemier, A van der Bent, et al.

Journal of Virological Methods|September 23, 1997

Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QTS M Bruisten, P Oudshoorn, P van Swieten, et al.

Protein Engineering|February 4, 1999

Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct foldingH J de Haard, B Kazemier, A van der Bent, et al.

Journal of Medical Virology|January 1, 1997

Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjectsA Cerino, M Bissolati, A Cividini, et al.

Clinical Nutrition ESPEN|May 23, 2017

Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetesK A Berk, T P Oudshoorn, A J M Verhoeven, et al.

The Journal of General Virology|January 8, 1999

Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoireJ J de Haard, B Kazemier, P Oudshoorn, et al.

Journal of Clinical Microbiology|May 15, 1999

Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as targetM P de Baar, A M van der Schoot, J Goudsmit, et al.

AIDS Research and Human Retroviruses|October 29, 2000

Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptationsD W Notermans, F de Wolf, P Oudshoorn, et al.

Pageof 2